Workflow
XILONG SCIENTIFIC(002584)
icon
Search documents
西陇科学(002584) - 年度关联方资金占用专项审计报告
2025-04-25 17:01
西陇科学股份有限公司 2024 年度 非经营性资金占用 及其他关联资金往来情况的专项说明 中兴财光华审专字(2025)第 207090 号 目 录 关于西陇科学股份有限公司 2024年度非经营性资金占用及 其他关联资金往来情况的专项说明 中兴财光华审专字(2025) 第 207090 号 西陇科学股份有限公司全体股东: 我们接受西陇科学股份有限公司(以下简称"西陇科学")委托,根据中国 注册会计师执业准则审计了西陇科学股份有限公司 2024年 12月 31 目的合并及 公司资产负债表,2024年度合并及公司利润表、合并及公司现金流量表、合并及 公司股东权益变动表和财务报表附注,并出具了中兴财光华审会字(2025)第 207003 号无保留意见审计报告。 根据《上市公司监管指引第 8 号 -- 上市公司资金往来、对外担保的监管要 求》(证监会公告[2022]26 导)及《深圳证券交易所上市公司自律监管指南第 1 号 -- 业务办理(2023年2月修订)》的要求,西陇科学编制了本专项说明所附 的 2024 年度非经营性资金占用及其他关联资金往来情况汇总表(以下简称"汇 总表")。 编制和对外披露汇总表,并确保其真 ...
西陇科学(002584) - 2024年度独立董事述职报告(刘晓暄)
2025-04-25 16:58
独立董事 2024 年度述职报告 西陇科学股份有限公司 独立董事 2024 年度述职报告(刘晓暄) 公司全体股东、股东代表: 2024 年 1 月 1 日至 2024 年 12 月 31 日期间作为西陇科学股份有限公司(以 下简称"公司")的独立董事,本人严格按照《公司法》、《证券法》、《深圳证 券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》、《上市公 司独立董事管理办法》等和公司章程、《独立董事工作制度》的规定和要求,本 着独立、客观、公正的原则,谨慎、认真、勤勉地履行了独立董事的职责,对规 定事项进行核查,切实维护公司和全体股东特别是中小股东的利益。现将本人 2024 年度履职情况汇报如下: 一、独立董事基本情况 (一)工作履历情况 刘晓暄,1957 年出生,博士,二级教授/博士生导师,欧洲自然科学院外籍 院士现任广东工业大学"材料科学与工程"(一级学科)省重点学科(攀峰计划)高分 子材料方向学科带头人,广东省光固化先进材料工程技术研究中心主任,高分子 材料与工程专业负责人。1982 年 1 月毕业于大连理工大学高分子化工专业,获工 学学士学位;2001 年 12 月中山大学博士研究生毕 ...
西陇科学(002584) - 董事会对独立董事独立性评估的专项意见
2025-04-25 16:58
西陇科学股份有限公司 根据《上市公司独立董事管理办法》、《深圳证券交易所股票上市规则》、 《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等 要求,西陇科学股份有限公司(以下简称"公司")董事会,就公司在任独立董事吴 守富、刘晓暄、曾幸荣的独立性情况进行评估并出具如下专项意见: 经核查独立董事吴守富、刘晓暄、曾幸荣的任职经历以及签署的相关自查文 件,上述人员未在公司担任除独立董事以外的任何职务,也未在公司主要股东公 司担任任何职务,与公司以及主要股东之间不存在利害关系或其他可能妨碍其进 行独立客观判断的关系。因此,公司独立董事符合《上市公司独立董事管理办法》、 《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》中 对独立董事独立性的相关要求。 西陇科学股份有限公司 董事会 2025 年 4 月 24 日 董事会关于独立董事独立性评估的专项意见 ...
西陇科学(002584) - 2024年度独立董事述职报告(吴守富)
2025-04-25 16:58
独立董事 2024 年度述职报告 西陇科学股份有限公司 独立董事 2024 年度述职报告(吴守富) 公司全体股东、股东代表: 2024 年 1 月 1 日至 2024 年 12 月 31 日期间作为西陇科学股份有限公司(以 下简称"公司")的独立董事,本人以维护公司、股东和投资者的利益为原则,根 据《公司法》《上市公司独立董事管理办法》《深圳证券交易所上市公司自律监 管指引第 1 号——主板上市公司规范运作》《公司章程》《公司独立董事工作制 度》及有关的规定和要求,谨慎、认真、勤勉地行使公司所赋予独立董事的权利 和职责。现将本人 2024 年度履职情况汇报如下: 一、独立董事基本情况 (一)工作履历情况 吴守富,1967 年出生,中国国籍,无境外永久居留权,毕业于安徽财贸学院 会计学专业,于上海财经大学完成金融投资与管理研修;高级会计师、注册会计 师、注册资产评估师、注册税务师,具有法律职业资格。现为上海通展会计师事 务所合伙人,曾于安徽华普会计师事务所担任高级审计经理、于安徽吉顺交通工 业有限公司担任财务总监、于上海天智资产管理有限公司担任财务总监、于安徽 飞彩(集团)有限公司及安徽飞彩车辆股份有限公司担任 ...
西陇科学(002584) - 独立董事年度述职报告
2025-04-25 16:58
独立董事 2024 年度述职报告 西陇科学股份有限公司 独立董事 2024 年度述职报告(曾幸荣) 公司全体股东、股东代表: 2024 年 1 月 1 日至 2024 年 12 月 31 日期间作为西陇科学股份有限公司(以 下简称"公司")的独立董事,本人严格按照《公司法》、《证券法》、《深圳 证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》、《上市 公司独立董事管理办法》等法律法规和公司章程、《独立董事工作制度》的规定 和要求,本着独立、客观、公正的原则,谨慎、认真、勤勉地履行了独立董事的 职责,对规定事项进行核查,切实维护公司和全体股东特别是中小股东的利益。 现将本人 2024 年度履职情况汇报如下: 一、独立董事基本情况 (一)工作履历情况 曾幸荣,1962 年出生,中国国籍,华南理工大学高分子材料专业工学博士。 现担任华南理工大学材料科学与工程学院教授、博士生导师,兼任广东省高性能 与功能高分子材料重点实验室副主任、高性能橡胶塑料与复合材料广东省高校重 点实验室主任、中国化工学会橡胶专业委员会名誉主任委员、广东省化工学会橡 胶专业委员会主任委员、广州市橡胶学会理事长等职务。主持完成了 ...
西陇科学(002584) - 公司章程
2025-04-25 16:58
西陇科学股份有限公司章程 二〇二五年四月 | 第一章 | 总则 | 4 | | --- | --- | --- | | 第二章 | 经营宗旨和范围 | 6 | | 第三章 | 股份 | 7 | | | 第一节 股份发行 | 7 | | | 第二节 股份增减和回购 | 7 | | | 第三节 股份转让 | 8 | | 第四章 | 股东和股东大会 | 10 | | | 第一节 股东 | 10 | | | 第二节 股东大会的一般规定 | 12 | | | 第三节 股东大会的召集 | 16 | | | 第四节 股东大会的提案与通知 | 17 | | | 第五节 股东大会的召开 | 19 | | | 第六节 股东大会的表决和决议 | 21 | | 第五章 | 董事会 | 26 | | | 第一节 董事 | 26 | | | 第二节 董事会 | 28 | | | 第三节 独立董事 | 34 | | 第六章 | 总裁及其他高级管理人员 | 39 | | 第七章 | 监事会 | 41 | | | 第一节 监事 | 41 | | | 第二节 监事会 | 41 | | 第八章 | | 财务会计制度、利润分配和审计 44 | | ...
西陇科学(002584) - 2025 Q1 - 季度财报
2025-04-25 16:40
Financial Performance - The company's operating revenue for Q1 2025 was ¥1,723,911,446.26, a decrease of 10.93% compared to ¥1,935,429,780.12 in the same period last year[5] - Net profit attributable to shareholders increased by 22.59% to ¥8,638,951.94 from ¥7,046,896.18 year-on-year[5] - The company reported a total of RMB 3,422,374,492.16 in current assets, an increase from RMB 3,287,777,849.87[13] - Total operating revenue decreased to ¥1,723,911,446.26 from ¥1,935,429,780.12, a decline of approximately 10.9% year-over-year[16] - Net profit increased to ¥8,957,870.83 from ¥7,263,074.61, representing a growth of approximately 23.3% year-over-year[17] - The total comprehensive income for the period was ¥8,964,243.79 compared to a loss of ¥67,223,564.84 in the previous period, showing a substantial turnaround[18] Cash Flow - The net cash flow from operating activities surged by 1,474.84% to ¥79,415,487.75, compared to ¥5,042,775.40 in the previous year[5] - Cash inflow from operating activities decreased to ¥1,863,781,431.44 from ¥2,466,064,277.67, a decline of about 24.4% year-over-year[19] - Total cash outflow from operating activities amounted to $1,784,365,943.69, down from $2,461,021,502.27, reflecting improved cash management[20] - The net cash flow from investing activities was -$18,400,711.13, an improvement from -$67,167,888.32, suggesting better investment efficiency[20] - Cash inflow from financing activities was $101,345,585.69, compared to $359,902,261.85 in the previous period, indicating a decrease in financing activities[20] - The net cash flow from financing activities was -$109,739,434.55, a decline from $36,759,763.89, highlighting challenges in financing[20] Assets and Liabilities - The total assets at the end of the reporting period were ¥4,841,141,343.99, reflecting a 2.66% increase from ¥4,715,579,071.58 at the end of the previous year[5] - The total liabilities increased to ¥2,525,063,576.39 from ¥2,409,792,792.73, an increase of about 4.8% year-over-year[14] - The company's total liabilities included accounts payable of RMB 676,587,567.61, up from RMB 615,763,209.95[13] - Contract liabilities rose by 42.05% to ¥62,544,039.68, attributed to an increase in advance payments received compared to the same period last year[7] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 80,499, with the largest shareholder holding 9.65% of the shares[8] - The company's basic earnings per share remained stable at ¥0.01, unchanged from the previous year[5] - Basic and diluted earnings per share remained stable at ¥0.01 for both periods[18] Other Financial Metrics - Deferred tax assets increased by 28.17% to ¥17,774,047.47, primarily due to an increase in recognized deferred tax assets[7] - Other income decreased by 38.93% to ¥8,044,225.65, mainly due to a reduction in government subsidies received during the reporting period[7] - The company reported a significant increase in credit impairment losses, which rose by 77.16% to ¥19,684,170.15, due to an increase in bad debt provisions[7] - Research and development expenses decreased to ¥19,695,576.61 from ¥27,256,625.41, a reduction of approximately 27.8% year-over-year[17] - Other comprehensive income after tax increased to ¥6,372.96 from a loss of ¥74,486,639.45, indicating a significant recovery[18] Compensation Commitments - The company committed to a net profit of no less than RMB 49 million for 2022, RMB 63 million for 2023, and RMB 78 million for 2024 from the acquisition of Aikewei Biotechnology[10] - The company has not yet determined whether it will bear compensation obligations related to the performance commitments of Aikewei Biotechnology[11]
西陇科学(002584) - 2024 Q4 - 年度财报
2025-04-25 16:40
Financial Performance - The company reported a significant increase in revenue, with a year-on-year growth of 15% in the last fiscal year[13]. - The company's operating revenue for 2024 reached ¥7,816,465,794, representing a 10.22% increase compared to ¥7,091,743,412 in 2022[18]. - Net profit attributable to shareholders was ¥61,773,364.9, an 85.24% increase from ¥33,347,824.3 in 2023[18]. - The net profit after deducting non-recurring gains and losses was ¥74,680,604.3, showing a significant increase of 159.62% from ¥28,764,969.0 in 2023[18]. - The net cash flow from operating activities was ¥302,163,807, a 206.13% increase compared to -¥284,714,593 in 2023[18]. - The company's revenue for 2024 reached approximately ¥7.82 billion, representing a year-on-year growth of 10.22% compared to ¥7.09 billion in 2023[58]. - Net profit attributable to shareholders increased by 85.24% year-on-year, driven by improved product structure and quality enhancements[51]. - The gross margin for electronic chemicals improved, with the annual sales volume of acetonitrile series products increasing by over 50% due to successful expansion projects[51]. - Sales revenue from specialized chemicals grew by 71.34% year-on-year, contributing significantly to overall revenue growth[59]. Investment and R&D - The company has invested in R&D for new products, with a budget allocation of 10 million RMB for the upcoming year[12]. - Research and development expenses increased by 14.84% to ¥109,902,730.43, indicating a focus on innovation and product development[70]. - The company is focusing on developing new products, including a new etching solution for dual-layer copper metal wiring, which has been completed and aims to enhance market share in electronic chemicals[71]. - A new environmentally friendly high-purity potassium persulfate production process has been developed, targeting the nitrogen removal market, with the project also completed[72]. - The company is developing a micro-reactor for the continuous production of uniform nano-silver, addressing issues of poor dispersion and irregular particle size in existing technologies[77]. - The company is committed to reducing environmental pollution through improved nitrogen oxide purification technologies[75]. Market Expansion and Strategy - The company is focusing on expanding its market presence, particularly in the electronic chemicals sector, which is expected to grow by 20% annually[12]. - The company has established a new subsidiary in Yunnan to enhance its production capabilities and market reach[12]. - The company has a well-established market network, achieving coverage in major domestic cities and expanding into Southeast Asia[49]. - The company aims to enhance its product offerings and service integration to gain a competitive edge, focusing on high brand recognition and comprehensive support services[105]. - The company plans to increase the proportion of high value-added products and improve automation and digitalization to enhance production efficiency and quality control[107]. Risk Management - The company has identified key risks in its operations, including supply chain disruptions, and has outlined mitigation strategies[5]. - The company continues to engage in hedging activities to mitigate price volatility risks associated with raw materials, ensuring stable operations[94]. - The company has established a comprehensive risk management framework for its hedging operations, including market, systemic, technical, operational, and credit risks[95]. - The company faces macroeconomic risks, including potential profit declines and inventory buildup if domestic economic growth slows[108]. - Safety production risks are a concern due to the hazardous nature of chemical products, and the company is enhancing safety measures and training to mitigate these risks[109]. - Environmental risks are heightened due to stricter regulations, prompting the company to adjust its product structure and optimize production processes for energy conservation and emission reduction[111]. Corporate Governance - The company has conducted multiple shareholder meetings to ensure compliance with legal regulations and enhance shareholder engagement[119]. - The sixth board of directors consists of nine members, including three independent directors, and held a total of 8 meetings during the reporting period[120]. - The company emphasizes accurate and timely information disclosure, with the chairman bearing primary responsibility for disclosure matters[125]. - The company maintains independence in its main business operations, including chemical reagent R&D, production, and sales, without reliance on controlling shareholders[127]. - The company has established a complete and independent personnel management system, ensuring that key management personnel do not hold positions in controlling shareholder entities[128]. Environmental Compliance - The company has implemented strict adherence to environmental protection laws, achieving 100% compliance in pollutant discharge[178]. - The wastewater treatment facility of Xilong Science has a designed capacity of 192 tons/day, achieving an effluent concentration of 21.75 mg/L for COD[181]. - The company has invested in environmental protection facilities, with Xilong Science investing 255 units, Foshan Xilong investing 86 units, and Sichuan Xilong investing 43 units for maintenance and updates[185]. - The company has successfully completed its annual emission reduction tasks as per regulations[185]. - The company was recognized as a "Good Environmental Enterprise" by the Sichuan Provincial Ecological Environment Department for the year 2023[188]. Employee Management - The total number of employees at the end of the reporting period is 1,173, with 487 in the parent company and 686 in major subsidiaries[162]. - The professional composition includes 466 production personnel, 266 sales personnel, 145 technical personnel, 58 financial personnel, and 238 administrative personnel[162]. - The company implements annual performance evaluations to determine salary adjustments and bonuses, promoting a performance-driven culture[163]. - The company has established special incentive plans aimed at motivating sales personnel and enhancing their potential[163]. - The training programs implemented during the reporting period aimed to enhance employee skills across various departments, including safety, management, and marketing[164]. Financial Management - The company has fully paid the remuneration for directors, supervisors, and senior management during the reporting period[149]. - The total pre-tax compensation for board members amounted to 5.6794 million yuan[150]. - The company plans to distribute a cash dividend of 0.2 RMB per 10 shares, totaling 11,704,328.44 RMB, based on a total share capital of 585,216,422 shares as of December 31, 2023[165]. - The cash dividend policies are in compliance with the company's articles of association and shareholder resolutions, ensuring clarity and transparency in the decision-making process[167]. - The company has established a comprehensive internal control system that adheres to relevant laws and regulations, with no significant deficiencies reported during the period[170].
西陇科学:2024年净利润6177.34万元,同比增长85.24%
news flash· 2025-04-25 16:39
西陇科学(002584)公告,2024年营业收入78.16亿元,同比增长10.22%。归属于上市公司股东的净利 润6177.34万元,同比增长85.24%。基本每股收益0.11元/股,同比增长83.33%。公司计划不派发现金红 利,不送红股,不以公积金转增股本。 ...
电子行业资金流入榜:沪电股份等10股净流入资金超亿元
Market Overview - The Shanghai Composite Index fell by 0.07% on April 25, with 21 out of the 28 sectors rising, led by utilities and communications, which increased by 1.36% and 1.15% respectively [1] - The electronic sector rose by 0.43% [1] - The real estate and coal sectors experienced the largest declines, falling by 0.60% and 0.59% respectively [1] Capital Flow Analysis - The net inflow of capital in the two markets was 4.975 billion yuan, with 14 sectors seeing net inflows [1] - The computer sector had the highest net inflow, totaling 3.368 billion yuan, while the utilities sector followed with a net inflow of 1.581 billion yuan [1] - A total of 17 sectors experienced net outflows, with the non-ferrous metals sector leading with a net outflow of 942 million yuan, followed closely by the basic chemicals sector with 930 million yuan [1] Electronic Sector Performance - The electronic sector saw a net inflow of 1.568 billion yuan, with 272 out of 461 stocks rising, including 5 hitting the daily limit [2] - The top three stocks with the highest net inflow were Huadian Co. (4.37 billion yuan), Luxshare Precision (2.83 billion yuan), and Dongshan Precision (1.73 billion yuan) [2] - Six stocks in the electronic sector experienced net outflows exceeding 100 million yuan, with the largest outflows from SMIC (246 million yuan), Xilong Science (190 million yuan), and Shengbang Co. (122 million yuan) [2][3] Electronic Sector Capital Inflow and Outflow Rankings - The top inflow stocks included: - Huadian Co. (5.72% increase, 436.55 million yuan inflow) - Luxshare Precision (2.76% increase, 283.40 million yuan inflow) - Dongshan Precision (3.48% increase, 173.16 million yuan inflow) [2] - The top outflow stocks included: - SMIC (-0.76% decrease, -246.14 million yuan outflow) - Xilong Science (-2.04% decrease, -190.37 million yuan outflow) - Shengbang Co. (-8.27% decrease, -121.81 million yuan outflow) [3]